Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | RAPT Therapeutics, Inc. | 3,413,552 | 9.9% | EDGAR |
SC 13G/A | 2024-02-14 | Redmile Group, LLC | RAPT Therapeutics, Inc. | 3,776,847 | 9.9% | EDGAR |
SC 13G/A | 2024-02-14 | Deep Track Capital, LP | RAPT Therapeutics, Inc. | 1,793,966 | 5.2% | EDGAR |
SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | RAPT Therapeutics, Inc. | 2,139,950 | 6.2% | EDGAR |
SC 13G | 2024-02-13 | VANGUARD GROUP INC | RAPT Therapeutics, Inc. | 2,056,221 | 6.0% | EDGAR |
SC 13G/A | 2024-02-09 | FMR LLC | RAPT Therapeutics, Inc. | 3,843,387 | 11.2% | EDGAR |
SC 13G/A | 2024-01-26 | BlackRock Inc. | RAPT Therapeutics, Inc. | 2,453,049 | 7.1% | EDGAR |
SC 13G/A | 2024-01-23 | STATE STREET CORP | RAPT Therapeutics, Inc. | - | 4.2% | EDGAR |
SC 13G | 2023-10-23 | Deep Track Capital, LP | RAPT Therapeutics, Inc. | 1,991,403 | 5.8% | EDGAR |
SC 13G/A | 2023-06-12 | PRICE T ROWE ASSOCIATES INC /MD/ | RAPT Therapeutics, Inc. | 3,556,462 | 10.4% | EDGAR |
SC 13G/A | 2023-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | RAPT Therapeutics, Inc. | 3,364,887 | 9.9% | EDGAR |
SC 13G/A | 2023-02-14 | Redmile Group, LLC | RAPT Therapeutics, Inc. | 3,679,838 | 9.9% | EDGAR |
SC 13G/A | 2023-02-14 | PERCEPTIVE ADVISORS LLC | RAPT Therapeutics, Inc. | 1,798,955 | 5.3% | EDGAR |
SC 13G/A | 2023-02-10 | FMR LLC | RAPT Therapeutics, Inc. | 3,927,400 | 11.6% | EDGAR |
SC 13G | 2023-02-10 | STATE STREET CORP | RAPT Therapeutics, Inc. | - | 5.7% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | RAPT Therapeutics, Inc. | 2,952,214 | 8.7% | EDGAR |
SC 13G/A | 2023-02-01 | BlackRock Inc. | RAPT Therapeutics, Inc. | 1,903,525 | 5.5% | EDGAR |
SC 13D/A | 2023-01-13 | COLUMN GROUP II, LP | RAPT Therapeutics, Inc. | 1,402,008 | 4.1% | EDGAR |
SC 13G | 2022-06-03 | Redmile Group, LLC | RAPT Therapeutics, Inc. | 3,199,363 | 9.9% | EDGAR |
SC 13G/A | 2022-04-11 | FMR LLC | RAPT Therapeutics, Inc. | 3,182,701 | 10.8% | EDGAR |